All Pharma News
Blade Therapeutics CEO, CFO appear to depart amid `transition` after nixed SPAC

Blade Therapeutics CEO, CFO appear to depart amid `transition` after nixed SPAC
Kyle LaHucik ENDPTS
15 Dec 2022
Share Share
Blade Presents Analyses from PI & Preclinical Studies of Cudetaxestat at ERSI

Blade Presents Analyses from PI & Preclinical Studies of Cudetaxestat at ERSI
BUSINESSWIRE
04 Sep 2022
Share Share
Blade Therapeutics to Participate in Panel Discussion at BTIG Biotech Conference

Blade Therapeutics to Participate in Panel Discussion at BTIG Biotech Conference
BUSINESSWIRE
01 Aug 2022
Share Share
Blade Therapeutics` SPAC merger is cancelled

Blade Therapeutics` SPAC merger is cancelled
J. Waldron FIERCEBIOTECH
14 Jun 2022
Share Share
BAC and Blade Therapeutics Postpone Extraordinary Meeting of Shareholders

BAC and Blade Therapeutics Postpone Extraordinary Meeting of Shareholders
PRNEWSWIRE
02 Jun 2022
Share Share
Blade Tx Presents PC Data on Differentiating Characteristics of Cudetaxestat

Blade Tx Presents PC Data on Differentiating Characteristics of Cudetaxestat
BUSINESSWIRE
18 May 2022
Share Share
Blade Tx Presents Data from PI and PC Studies of Cudetaxestat at ATS

Blade Tx Presents Data from PI and PC Studies of Cudetaxestat at ATS
BUSINESSWIRE
16 May 2022
Share Share
BAC and Blade Tx Announce Effectiveness of Registration Statement on Form S-4

BAC and Blade Tx Announce Effectiveness of Registration Statement on Form S-4
PRNEWSWIRE
09 May 2022
Share Share
Biotech Acquisition Co. Tells Filing of 1st Amendment to Registration Statement

Biotech Acquisition Co. Tells Filing of 1st Amendment to Registration Statement
PRNEWSWIRE
04 Apr 2022
Share Share
Blade Therapeutics Announces Feedback from FDA on End-of-Phase 1 Data Package

Blade Therapeutics Announces Feedback from FDA on End-of-Phase 1 Data Package
BUSINESSWIRE
04 Apr 2022
Share Share